Literature DB >> 1986598

Antiepileptic medication in pregnancy: late effects on the children's central nervous system development.

M C van der Pol1, M Hadders-Algra, H J Huisjes, B C Touwen.   

Abstract

In a follow-up study long-term effects of antenatal exposure to two anticonvulsant drugs, phenobarbital and carbamazepine on central nervous system development were evaluated. Children aged 6 to 13 years of epileptic mothers who used phenobarbital (n = 13), carbamazepine (n = 12), phenobarbital plus carbamazepine (n = 12), or no medication (n = 24) during pregnancy were studied. None of the mothers had seizures during pregnancy. A control group carefully matched for confounding variables was selected of children of nonepileptic mothers (n = 61). Minor and major congenital anomalies appeared to be more related to mother's epilepsy than to maternal medication. There were no neurologic differences between the groups. Exposure to phenobarbital was associated with smaller head circumference. An accompanying negative effect of phenobarbital on cognitive development was suggested. Further research on this intriguing phenomenon seems warranted.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986598     DOI: 10.1016/0002-9378(91)90640-d

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

Review 1.  Anticonvulsants and breast feeding: a critical review.

Authors:  B Bar-Oz; I Nulman; G Koren; S Ito
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

Review 2.  Developmental neuropathology of environmental agents.

Authors:  Lucio G Costa; Michael Aschner; Annabella Vitalone; Tore Syversen; Offie Porat Soldin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

Review 3.  GABAA receptors, anesthetics and anticonvulsants in brain development.

Authors:  Oliver Henschel; Keith E Gipson; Angelique Bordey
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

4.  Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy.

Authors:  A Ornoy; E Cohen
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

Review 5.  Advances in Epidemiological Methods and Utilisation of Large Databases: A Methodological Review of Observational Studies on Central Nervous System Drug Use in Pregnancy and Central Nervous System Outcomes in Children.

Authors:  Zixuan Wang; Phoebe W H Ho; Michael T H Choy; Ian C K Wong; Ruth Brauer; Kenneth K C Man
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

6.  Alterations in hippocampal hemicholinium-3 binding and related behavioural and biochemical changes after prenatal phenobarbitone exposure.

Authors:  E H Zahalka; M Rehavi; M E Newman; J Yanai
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

Review 7.  Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies.

Authors:  Ryan Banach; Radinka Boskovic; Thomas Einarson; Gideon Koren
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 8.  Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero.

Authors:  Rebecca L Bromley; Gus A Baker; Kimford J Meador
Journal:  Curr Opin Neurol       Date:  2009-04       Impact factor: 5.710

Review 9.  An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes.

Authors:  Elizabeth E Gerard; Kimford J Meador
Journal:  J Pediatr Genet       Date:  2015-06

Review 10.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.